1,613
Views
0
CrossRef citations to date
0
Altmetric
Review Article

Evaluation of the carcinogenicity of carbon tetrachloride

ORCID Icon, , & ORCID Icon

References

  • Albano, E., K. A. K. Lott, T. F. Slater, A. Stier, M. C. R. Symons, and A. Tomasi. 1982. Spin-trapping studies on the free-radical products formed by metabolic activation of carbon tetrachloride in rat liver microsomal fractions isolated hepatocytes and in vivo in the rat. Biochem. J. 204 (2):593–603. doi:10.1042/bj2040593.
  • Alpert, A. E., A. V. Arkhangelsky, A. M. Lunts, and N. P. Panina. 1972. Experimental hepatopathies and carcinomas of the breast in rats. Bjull. Eksp. Biol. Med 74 (4):1299–301. doi:10.1007/BF00801865.
  • Andersen, M. E., E. Meek, G. A. Boorman, D. J. Brusick, S. M. Cohen, Y. P. Dragan, C. B. Frederick, J. I. Goodman, G. C. Hard, E. J. O’Flaherty, et al. 2000. Lessons learned in applying the U.S. EPA’s proposed cancer guidelines to specific compounds. Toxicol. Sci. 53 (2):159–72. doi:10.1093/toxsci/53.2.159.
  • Andervont, H. B. 1958. Induction of hepatomas in strain C3H mice with 4-o-tolyazoo-toluidine and carbon tetrachloride. J. Natl. Cancer Inst. 20 (2):431–38. doi:10.1093/jnci/20.2.431.
  • Ansari, G. A., M. T. Moslen, and E. S. Reynolds. 1982. Evidence for in vivo covalent binding of CCl3 derived from CCl4 to cholesterol of rat liver. Biochem. Pharmacol. 31 (21):3509–10. doi:10.1016/0006-2952(82)90634-7.
  • Araki, A., N. Kamigaito, T. Sasaki, and T. Matsushima. 2004. Mutagenicity of carbon tetrachloride and chloroform in Salmonella typhimurium TA98, TA100, TA1535, and TA1537, and Escherichia coli WP2uvrA/pKM101 and WP2/pKM101, using a gas exposure method. Environ. Mol. Mutagen. 43 (2):128–33. doi:10.1002/em.20005.
  • ATSDR (Agency for Toxic Substances and Disease Registry). 2005. Toxicological profile for carbon tetrachloride (update), Agency for toxic substances and disease registry. Atlanta, GA: U.S. Department of Health and Human Services.
  • Benson, J. M., and D. L. Springer. 1999. Improved risk estimates for carbon tetrachloride. Finalreport. New Mexico: U.S. Department of Energy. Report DE-FC04-96AL76406. Project No. 54940.
  • Blair, A., P. Decoufle, and D. Grauman. 1979. Causes of death among laundry and dry cleaning workers. Am. J. Public Heath 69 (5):508–11. doi:10.2105/ajph.69.5.508.
  • Blair, A., P. P. Hartge, A. Stewart, M. McAdams, and J. Lubin. 1998. Mortality and cancer incidence of aircraft maintenance workers exposed to trichloroethylene and other organic solvents and chemicals: Extended follow up. Occup. Environ. Med 55 (3):161–71. doi:10.1136/oem.55.3.161.
  • Blair, A., P. A. Stewart, P. E. Tolbert, D. Grauman, F. X. Moran, J. Vaught, and J. Rayner. 1990. Cancer and other causes of death among a cohort of dry cleaners. Br. J. Ind Med 47 (3):162–68. doi:10.1136/oem.47.3.162.
  • Boobis, A. R., S. M. Cohen, V. Dellarco, D. McGregor, M. E. Meek, C. Vickers, D. Willcocks, and W. Farland. 2006. IPCS framework for analyzing the relevance of a cancer mode of action for humans. Crit. Rev. Toxicol. 36 (10):781–92. doi:10.1080/10408440600977677.
  • Boobis, A. R., J. E. Doe, B. Heinrich-Hirsch, M. E. Meek, S. Munn, M. Ruchirawat, J. Schlatter, J. Seed, and C. Vickers. 2008. IPCS framework for analyzing the relevance of a noncancer mode of action for humans. Crit. Rev. Toxicol. 38 (2):87–96. doi:10.1080/10408440701749421.
  • Brogan, W. C., and H. D. Colby. 1983. Carbon tetrachloride (CCl4) toxicity in the guinea pig adrenal cortex. W V Med. J 79 (12):274.
  • Bruckner, J. V., H. J. Kim, S. Muralidhara, and J. M. Gallo. 1990. Influence of Route and Pattern of Exposure on the Pharmacokinetics and Hepatotoxicity of Carbon Tetrachloride. ADA223461.
  • Bruckner, J. V., W. F. MacKenzie, S. Muralidhara, R. Luthra, G. M. Kyle, and D. Acosta. 1986. Oral toxicity of carbon tetrachloride: Acute, subacute, and subchronic studies in rats. Fundam. Appl. Toxicol 6 (1):16–34. doi:10.1016/0272-0590(86)90260-5.
  • Bulera, S. J., S. M. Eddy, E. Ferguson, T. A. Jatkoe, J. F. Reindel, M. R. Bleavins, and F. A. De La Iglesia. 2001. RNA expression in the early characterization of hepatotoxicants in wistar rats by high-density DNA microarrays. Hepatology 33 (5):1239–58. doi:10.1053/jhep.2001.23560.
  • Cantor, K. P., P. A. Stewart, L. A. Brinton, and M. Dosemeci. 1995. Occupational exposures and female breast cancer mortality in the United States. J. Occup. Environ. Med. 37 (3):336–48. doi:10.1097/00043764-199503000-00011.
  • Castro, J. A., and M. I. Diaz Gomez. 1972. Studies on the irreversible binding of 14C-CCl4 to microsomal lipids in rats under varying experimental conditions. Toxicol. Appl. Pharmacol 23 (4):541–52. doi:10.1016/0041-008x(72)90095-6.
  • Castro, G. D., M. I. D. Díaz Gómez, and J. A. Castro. 1989. Species differences in the interaction between CCI 4 reactive metabolites and liver DNA or nuclear protein fractions. Carcinogenesis 10 (2):289–94. doi:10.1093/carcin/10.2.289.
  • Checkoway, H., T. Wilcosky, P. Wolf, and H. Tyroler. 1984. An evaluation of the associations of leukemia and rubber industry solvent exposures. Am. J. Ind. Med. 5 (3):239–49. doi:10.1002/ajim.4700050307.
  • Cho, K. J., and J. J. Jang. 1993. Effects of carbon tetrachloride, ethanol and acetaldehyde on diethylnitrosamine-induced hepatocarcinogenesis in rats. Cancer Lett. 70 (1–2):33–39. doi:10.1016/0304-3835(93)90071-g.
  • Cohen, S. M. 1999. Infection, cell proliferation, and malignancy. In Microbes and Malignancy: Infection as a Cause of Cancer, ed. J. Parsonnet, and S. Horning, pp. 89–106. Oxford, England: Oxford University Press.
  • Cohen, S. M. 2010. Evaluation of possible carcinogenic risk to humans based on liver tumors in rodent assays: The two-year bioassay is no longer necessary. Toxicol .Pathol 38 (3):487–501. doi:10.1177/0192623310363813.
  • Colby, H. D., H. Purcell, S. Kominami, S. Takemori, and D. C. Kossor. 1994. Adrenal activation of carbon tetrachloride: Role of microsomal P450 isozymes. Toxicology 94 (1–3):31–40. doi:10.1016/0300-483x(94)90026-4.
  • Cole, L. J., and P. C. Nowell. 1964. Accelerated induction of hepatomas in fast neutron-irradiated mice injected with carbon tetrachloride. Ann. N. Y. Acad. Sci. 114 (1):259–67. doi:10.1111/j.1749-6632.1964.tb53581.x.
  • Columbano, A., G. M. Ledda-Columbano, M. Pibiri, R. Piga, H. Shinozuka, V. De Luca, F. Cerignoli, and M. Tripodi. 1997. Increased expression of c-fos, c-jun and LRF-1 is not required for in vivo priming of hepatocytes by the mitogen TCPOBOP. Oncogene 14 (7):857–63. doi:10.1038/sj.onc.1200891.
  • Condie, L. W., R. D. Laurie, T. Mills, M. Robinson, and J. P. Bercz. 1986. Effect of gavage vehicle on hepatotoxicity of carbon tetrachloride in CD-1 mice: Corn oil versus tween-60 aqueous emulsion. Fundam. Appl. Toxicol 7 (2):199–206. doi:10.1016/0272/0590(86)90148-x.
  • Coni P., F. Bignone, G. Pichiri, G. Ledda-Columbano, A. Columbano, P. Rao, S. Rajalakshmi and D. Sarma. 1989. “Studies on the kinetics of expression of cell cycle dependent proto-oncogenes during mitogen-induced liver cell proliferation.“ Cancer Letters 47 (1–2): 115–119. doi:10.1016/0304-3835(89)90186-9.
  • Costa, A., G. Weber, F. S. O. Bartoloni, and G. Campana. 1963. Experimental cancerous cirrhosis from carbon tetrachloride in rats. Arch. DeVecchi 39:303–56.
  • Curtis, H. J., J. Tilley, and C. Crowley. 1964. The elimination of chromosome aberrations in liver cells by cell division. Radiat. Res. 22 (4):730–34. doi:10.2307/3571554.
  • Dai, Y., and A. I. Cederbaum. 1995. Inactivation and degradation of human cytochrome P4E1 by CCl4 in a transfected HepG2 cell line. J. Pharmacol. Exp. Ther. 275 (3):1614–22.
  • Delaney, B., and N. E. Kaminski. 1993. Induction of serum-borne immunomodulatory factors in B6C3F1 mice by carbon tetrachloride. I. Carbon tetrachloride-induced suppression of helper T-lymphocyte function is mediated by a serum borne factor. Toxicology 85 (1):67–84. doi:10.1016/0300-483x(93)90083-5.
  • DeLellis, R. A., R. V. Lloyd, P. U. Heitz, and C. Eng, eds. 2004. “Pathology and genetics of tumours of endocrine organs.“ In World Health Organization Classification of Tumours. Lyon, France: IARC Press.
  • Della Porta, G. D., B. Terracini, and P. Shubik. 1961. Induction with carbon tetrachloride of liver-cell carcinomas in hamsters. J. Natl. Cancer Inst. 26:855–63. doi:10.1093/jnci/26.4.855.
  • Diaz Gomez, M. I., and J. A. Castro. 1980. Covalent binding of carbon tetrachloride metabolites to liver nuclear DNA, proteins, and lipids. Toxicol. Appl. Pharmacol 56 (2):199–206. doi:10.1016/0041-008x(80)90290-2.
  • Doolittle, D. J., G. Muller, and H. E. Scribner. 1987. Relationship between hepatotoxicity and induction of replicative DNA synthesis following single or multiple doses of carbon tetrachloride. J. Toxicol. Environ Health 22 (1):63–78. doi:10.1080/15287398709531051.
  • Dragani, T. A., G. Manenti, and G. Della Porta. 1986. Enhancing effects of carbon tetrachloride in mouse hepatocarcinogenesis. Cancer Lett. 31 (2):171–79. doi:10.1016/0304-3835(86)90008-x.
  • Dragan, Y. P., L. Sargent, Y. D. Xu, H. C. Pitot, and H. C. Pitot. 1993. The initiation-promotion-progression model of rat hepatocarcinogenesis. Proc. Soc. Exp. Biol. Med. 202 (1):16–24. doi:10.3181/00379727-202-43511c.
  • Eastmond, D. A. 2008. Evaluating genotoxicity data to identify a mode of action and its application in estimating cancer risk at low doses: A case study involving carbon tetrachloride. Environ. Mol. Mutagen. 49 (2):132–41. doi:10.1002/em.20368.
  • Edwards, J. E. 1941. Hepatomas in mice induced with carbon tetrachloride. J. Natl. Cancer Inst. 2:197–99. doi:10.1093/jnci/2.2.197.
  • Edwards, J. E., and A. J. Dalton. 1942. Induction of cirrhosis of the liver and of hepatomas in mice with carbon tetrachloride. J. Natl. Cancer Inst. 3:19–41. doi:10.1093/jnci/3.1.19.
  • Edwards, J., W. E. Heston, and A. J. Dalton. 1942. Induction of the carbon tetrachloride hepatoma in strain L mice. J. Natl. Cancer Inst. 3:297–301. doi:10.1093/jnci/3.3.297.
  • Eschenbrenner, A. B., and E. Miller. 1946. Liver necrosis and the induction of carbon tetrachloride hepatomas in strain a mice. J. Natl. Cancer Inst. 6:325–41. doi:10.1093/jnci/6.6.325.
  • Everds, N. E., P. W. Snyder, K. L. Bailey, B. Bolon, D. M. Creasy, G. L. Foley, T. J. Rosol, and T. Sellers. 2013. Interpreting stress responses during routine toxicity studies: A review of the biology, impact, and assessment. Toxicol. Pathol 41 (4):560–614. doi:10.1177/0192623312466452.
  • Fanelli, S. L., and J. A. Castro. 1995. Covalent binding of carbon tetrachloride reactive metabolites to liver microsomal and nuclear lipid and phospholipid classes from sprague dawley and Osborne Mendel male rats. Teratogen. Carcinogen. Mutagen 15 (4):155–66. doi:10.1002/tcm.1770150402.
  • Farber, E., and D. S. R. Sarma. 1987. Hepatocarcinogenesis: A dynamic cellular perspective. Lab. Invest. 56 (1):4–22.
  • Fishbein, L., and K. L. Nathanson. 2012. Pheochromocytoma and paraganglioma: Understanding the complexities of the genetic background. Cancer. Genet 205 (1–2):1–11. doi:10.1016/j.cancergen.2012.01.009.
  • Fountoulakis, M., M. C. de Vera, F. Crameri, F. Boess, R. Gasser, S. Albertini, and L. Suter. 2002. Modulation of gene and protein expression by carbon tetrachloride in the rat liver. Toxicol. Appl. Pharmacol 183 (1):71–80. doi:10.1006/taap.2002.9460.
  • Frezza, E. E., G. E. Gerunda, F. Farinati, N. DeMaria, A. Galligioni, F. Plebani, A. Giocomin, and D. H. Van Thiel. 1994. CCl4-induced liver cirrhosis and hepatocellular carcinoma in rats: Relationship to plasma zinc, copper and estradiol levels. Hepatogastroenterology 41 (4):367–69.
  • Furihata, C., and T. Suzuki. 2023. Short-term in vivo testing to discriminate genotoxic carcinogens from non-genotoxic carcinogens and non-carcinogens using next-generation RNA sequencing, DNA microarray, and qPCR. Genes. and Environ 45 (1):7. doi:10.1186/s41021-023-00262-9.
  • Greim, H., A. Hartwig, U. Reuter, H. B. Richter-Reichhelm, and H. W. Thielmann. 2009. Chemically induced pheochromocytomas in rats: Mechanisms and relevance for human risk assessment. Crit. Rev. Toxicol. 39 (8):695–718. doi:10.1080/10408440903190861.
  • Habs, H., K. Künstler, D. Schmähl, and L. Tomatis. 1983. Combined effects of fast-neutron irradiation and subcutaneously applied carbon tetrachloride or chloroform in C57B16 mice. Cancer Lett. 20 (1):13–20. doi:10.1016/0304-3835(83)90181-7.
  • Halver, J. E. 1967. Crystalline aflatoxin and other vectors for trout hepatoma. In Trout Hepatoma Research Conference Papers, ed. J. E. Halver, and I. A. Mitchell, Washington, DC: Bureau of Sports Fisheries and Wildlife. pp. 78a
  • Hard, G. C., K. J. Johnson, and S. M. Cohen. 2009. A comparison of rat chronic progressive nephropathy with human renal disease—implications for human risk assessment. Crit. Rev. Toxicol. 39 (4):332–46. doi:10.1080/10408440802368642.
  • Hartley, D. P., K. L. Kolaja, J. Reichard, and D. R. Petersen. 1999. 4-Hydroxynonenal and malondialdehyde hepatic protein adducts in rats treated with carbon tetrachloride: Immunochemical detection and lobular localization. Toxicol. Appl. Pharmacol 161 (1):23–33. doi:10.1006/taap.1999.8788.
  • Haseman, J. K. 1983. A reexamination of false-positive rates for carcinogenesis studies. Fundam. Appl. Toxicol 3 (4):334–39. doi:10.1016/s0272-0590(83)80148-1.
  • Holden, P. R., N. H. James, A. N. Brooks, R. A. Roberts, I. Kimber, and W. D. Pennie. 2000. Identification of a possible association between carbon tetrachloride-induced hepatotoxicity and interleukin-8 expression. J. Biochem. Mol. Toxicol. 14:283–90. doi:10.1002/1099-0461(2000)14:5<283:AID-JBT7>3.0.CO;2-S.
  • Holsapple, M. P., H. C. Pitot, S. H. Cohen, A. R. Boobis, J. E. Klaunig, T. Pastoor, V. L. Dellarco, and Y. P. Dragan. 2006. Mode of action in relevance of rodent liver tumors to human cancer risk. Toxicol. Sci. 89 (1):51–56. doi:10.1093/toxsci/kfj001.
  • IARC (International Agency for Research on Cancer). Carbon Tetrachloride. 1999. IARC monographs on the evaluation of carcinogenic risk to humans, lyon. France 71: 401–32.
  • IARC (International Agency for Research on Cancer). Solvents. 1979. IARC monographs on the evaluation of carcinogenic risk to humans, lyon. France 20: 371–402.
  • IPCS (International Programme on Chemical Safety). 1999. Carbon tetrachloride. Geneva, Switzerland: International Programme for Chemical Safety.
  • JBRC (Japan Bioassay Research Center). Subchronic inhalation toxicity and carcinogenicity studies of carbon tetrachloride in F344 rats and BDF1 mice (Studies Nos. 0020, 0021, 0043, and 0044). 1998. Kanagawa, Japan Industrial Safety and Health Association (Unpublished report to the Ministry of Labor). Hirasawa Hadano Kanagawa, 257 Japan.
  • Jeon, Y. J., S. H. Han, K. H. Yang, and N. E. Kaminski. 1997. Induction of liver-associated transforming growth factor β1 (TGF-β1) mRNA expression by carbon tetrachloride leads to the inhibition of T helper 2 cell-associated lymphokines. Toxicol. Appl. Pharmacol 144 (1):27–35. doi:10.1006/taap.1997.8126.
  • Johnstone, R. T. 1948. Occupational Medicine and Industrial Hygiene, pp. 148–58. Louis, MO: C. V. Mosby Co. St.
  • Kanematsu, T. 1976. Promoting effect of carbon tetrachloride on azo-dye hepatocarcinogenesis in rats. Fukuoka. Igaku Zasshi 67:134–45.
  • Katagiri, T., K. Nagano, S. Aiso, H. Senoh, Y. Sakura, T. Takeuchi, and M. Okudaira. 1998. A pathological study on spontaneous hepatic neoplasms in BDF1 mice. J. Toxicol. Pathol 11 (1):21–21. doi:10.1293/tox.11.21.
  • Kato, K., T. Kawai, M. Fujii, Y. Bunai, H. Shima, and M. Takahashi. 1985. Enhancing effect of preadministration of carbon tetrachloride on methylazoxymethanol acetate-induced intestinal carcinogenesis. J. Toxicol Sci 10 (4):289–93. doi:10.2131/jts.10.289.
  • Kauppinen, T., E. Pukkala, A. Saalo, and A. J. Sasco. 2003. Exposure to chemical carcinogens and risk of cancer among Finnish laboratory workers. Am. J. Ind. Med. 44 (4):343–50. doi:10.1002/ajim.10278.
  • Kawasaki, H. 1965. Development of tumor in the course of spontaneous restoration of carbon tetrachloride induced cirrhosis of the liver in rats. Kurume Med. J 12 (1):37–42. doi:10.2739/kurumemedj.12.37.
  • Kiplinger, G. F., and C. J. Kensler. 1963. Failure of phenoxybenzamine to prevent formation of hepatomas after chronic carbon tetrachloride administration. J. Natl. Cancer Inst. 30:837–43. doi:10.1093/jnci/30.4.837.
  • Klaunig, J. E., and Z. Wang. 2018. Chemical Carcinogenesis. In Casarett & Doull’s Toxicology: The Basic Science of Poisons, ed. C. D. Klaassen, pp. 705–813. 9th ed. New York: McGraw-Hill.
  • Koch, C. A., K. Pacak, and G. P. Chrousos. 2002. The molecular pathogenesis of hereditary and sporadic adrenocortical and adrenomedullary tumors. J. Clin. Endocrinol. Metab. 87 (12):5367–84. doi:10.1210/jc.2002-021069.
  • Krokan, H., R. C. Grafstrom, K. Sundqvist, H. Esterbauer, and C. C. Harris. 1985. Cytotoxicity, thiol depletion and inhibition of O6-methylguanine-DNA methyltransferase by various aldehydes in cultured human bronchial fibroblasts. Carcinogenesis 6 (12):1755–59. doi:10.1093/carcin/6.12.1755.
  • Kroner, H. 1982. The intracellular distribution of liver cell calcium in normal rats and one hour after administration of carbon tetrachloride. Biochem. Pharmacol. 31 (6):1069–73. doi:10.1016/0006-2952(82)90344-6.
  • Krynitz, B., G. Edgren, B. Lindelof, E. Baecklund, C. Brattstrom, H. Wilczek, and K. E. Smedby. 2013. Risk of skin cancer and other malignancies in kidney, liver, heart and lung transplant recipients 1970 to 2008–a Swedish population-based study. Int. J. Cancer 132 (6):1429–38. doi:10.1002/ijc.27765.
  • Kubale, T. L., R. D. Daniels, J. H. Yiin, J. Couch, M. K. Schubauer-Berigan, G. M. Kinnes, S. R. Silver, S. J. Nowlin, and P. Chen. 2005. A nested case-control study of leukemia mortality and ionizing radiation at the Portsmouth Naval Shipyard. Radiat. Res. 164 (6):810–19. doi:10.1667/rr3473.1.
  • Lai E. K., P. B. McCay, N. Toshikazu and F. Kuo-Lan. 1979. “In vivo spin-trapping of trichloromethyl radicals formed from CCl4.“ Biochemical Pharmacology 28 (14): 2231–2235. doi:10.1016/0006-2952(79)90212-0.
  • Lebrec, H., F. R. Brennan, H. Haggerty, D. Herzyk, C. Kamperschroer, C. C. Maier, R. Ponce, B. D. Preston, D. Weinstock, and R. D. Mellon. 2016. HESI/FDA workshop on immunomodulators and cancer risk assessment: Building blocks for a weight-of-evidence approach. Regul. Toxicol. Pharmacol. 75:72–80. doi:10.1016/j.yrtph.2015.12.018.
  • Lee, V. M., R. G. Cameron, and M. C. Archer. 1998. Zonal location of compensatory hepatocyte proliferation following chemically induced hepatotoxicity in rats and humans. Toxicol. Pathol 26 (5):621–27. doi:10.1177/019262339802600505.
  • Lee, P. Y., P. B. McCay, and K. R. Hornbrook. 1982. Evidence for carbon tetrachloride-induced lipid peroxidation in mouse liver. Biochem. Pharmacol. 31 (3):405–09. doi:10.1016/0006-2952(82)901089-7.
  • Lemonnier, F. J., J. M. Scotto, and C. Thuong-Trieu. 1974. Disturbances in tryptophan metabolism after a single dose of Aflatoxin Bl and chronic intoxication with carbon tetrachloride. J. Natl. Cancer Inst. 53 (3):745–49. doi:10.1093/jnci/53.3.745.
  • Letteron, P., G. Labbe, C. Degott, A. Berson, B. Fromenty, M. Delaforge, D. Larrey, and D. Pessayre. 1990. Mechanism for the protective effects of silymarin against carbon tetrachloride-induced lipid peroxidation and hepatotoxicity in mice. Evidence that silymarin acts both as an inhibitor of metabolic activation and as a chain-breaking antioxidant. Biochem. Pharmacol. 39 (12):2027–34. doi:10.1016/0006-2952(90)90625-u.
  • Long, R. M., and L. Moore. 1986. Elevated cytosolic calcium in rat hepatocytes exposed to carbon tetrachloride. J. Pharmacol. Exp. Ther. 238 (1):186–91.
  • Luckey, S. W., and D. R. Petersen. 2001. Activation of Kupffer cells during the course of carbon tetrachloride-induced liver injury and fibrosis in rats. Exp. Mol. Pathol. 71 (3):226–40. doi:10.1006/exmp.2001.2399.
  • Luster, M. I., P. P. Simeonova, R. M. Gallucci, J. M. Matheson, and B. Yucesoy. 2000. Immunotoxicology: Role of inflammation in chemical-induced hepatotoxicity. Int. J. Immunopharmacol. 22 (12):1143–47. doi:10.1016/s0192-0561(00)00073-4.
  • Manibusan, M. K., M. Odin, and D. A. Eastmond. 2007. Postulated carbon tetrachloride mode of action: A review. J. Environ Sci Health C Environ Carcinog Ecotoxicol Rev 25 (3):185–209. doi:10.1080/10590500701569398.
  • Manno, M. M. R., C. Grossi, M. Sbrana, and C. Sbrana. 1996. Potentiation of occupational carbon tetrachloride toxicity by ethanol abuse. Human Exp. Toxicol 15 (4):294–300. doi:10.1177/096032719601500404.
  • Maronpot, R. R., J. K. Haseman, G. A. Boorman, S. E. Eustis, G. N. Rao, and J. E. Huff. 1987. Liver lesions in B6C3F1 mice: The national toxicology program, experience and position. Arch. Toxicol. Suppl 10:10–26. doi:10.1007/978-3-642-71617-1_2.
  • Maronpot, R. R., H. Witschi, L. H. Smith, and J. L. McCoy.1983.“Recent experience with the strain a mouse pulmonary tumor bioassay model”Short-term bioassays in the analysis of complex environmental mixtures II.ed. In M. D. Waters, S. S. Sandhu, J. Lewtas, L. Claston, N. Chernoff, and S. NesnowVol. 27.Plenum Presspp. 341–49.10.1007/978-1-4613-3611-2_24
  • Marshall, K. A., and L. H., Pottenger. 2016. “Chlorocarbons and Chlorohydrocarbons.“ Kirk-Othmer Encyclopedia of Chemical Technology. 4th ed. Wiley-Interscience.
  • Martinez, M., M. Mourelle, and P. Muriel. 1995. Protective effect of colchicine on acute liver damage induced by CCl4. Role of cytochrome P-450. J. Appl. Toxicol. 15 (1):49–52. doi:10.1002/jat.250150111.
  • McConnell, E. E., H. A. Sollevelt, J. A. Swenberg, and G. A. Boorman. 1986. Guidelines for combining neoplasms for evaluation of rodent carcinogenesis studies. J. Natl. Cancer Inst. 76 (2):283–89.
  • McGregor, D., and M. Lang. 1996. Carbon tetrachloride: Genetic effects and other modes of action. Mutat. Res 366 (3):181–95. doi:10.1016/s0165-1110(96)90027-5.
  • Meek, M. E., J. R. Bucher, S. M. Cohen, V. Dellarco, R. N. Hill, L. D. Lehman-McKeeman, D. G. Longfellow, T. Pastoor, J. Seed, and D. E. Patton. 2003. A framework for human relevance analysis of information on carcinogenic modes of action. Crit. Rev. Toxicol. 33 (6):591–653. doi:10.1080/713608373.
  • Menegazzi, M., A. Carcereri-De Prati, H. Suzuki, H. Shinozuka, M. Pibiri, R. Piga, A. Columbano, and G. M. Ledda-Columbano. 1997. Liver cell proliferation induced by nafenopin and cyproterone acetate is not associated with increases in activation of transcription factors NF-kappaB and AP-1 or with expression of tumor necrosis factor alpha. Hepatology 25 (3):585–92. doi:10.1002/hep.510250316.
  • Nagano, K., T. Nishizawa, S. Yamamoto, and T. Matsushima 1998. Inhalation carcinogenesis studies of six halogenated hydrocarbons in rats and mice. In: Advances in the prevention of occupational respiratory diseases: proceedings of the 9thinternational conference on occupational respiratory diseases, ed. K. Chiyotani, Y. Hosoda, and Y. Aizawa, 741–46. New York: Elsevier.
  • Nagano, K., T. Sasaki, Y. Umeda, T. Nishizawa, N. Ikawa, H. Ohbayashi, H. Arito, S. Yamamoto, and S. Fukushima. 2007a. Inhalation carcinogenicity and chronic toxicity of carbon tetrachloride in rats and mice. Inhal. Toxicol 19 (13):1089–103. doi:10.1080/08958370701628770.
  • Nagano, K., Y. Umeda, M. Saito, T. Nishizawa, N. Ikawa, H. Arito, S. Yamamoto, and S. Fukushima. 2007b. Thirteen-week inhalation toxicity of carbon tetrachloride in rats and mice. J. Occup Health 49 (4):249–59. doi:10.1539/joh.49.249.
  • Nakata, R., I. Tsukamoto, M. Miyoshi, and S. Kojo. 1985. Liver regeneration after carbon tetrachloride intoxication in the rat. Biochem. Pharmacol. 34 (4):586–88. doi:10.1016/0006-2952(85)90195-9.
  • NCI (National Cancer Institute). 1976a. Report on the carcinogenesis bioassay of chloroform. CAS No. 67-66-3. U.S. Department of Health, Education and Welfare.
  • NCI (National Cancer Institute). 1976b. Report on the carcinogenesis bioassay of trichloroethylene. CAS No. 79-01-6. U.S. Department of Health, Education and Welfare.
  • New, P. S., G. D., Lubash, Scherr, L., and Rubin, A. L. 1962. Acute renal failure associated with carbon tetrachloride intoxication. J. Am Med Assoc 181 903–906. doi:10.1001/jama.1962.03050360089019c
  • Noguchi, T., K. L. Fong, E. K. Lai, S. S. Alexander, M. M. King, L. Olson, J. L. Poyer, and P. B. McCay. 1982b. Specificity of a phenobarbital-induced cytochrome P-450 for metabolism of carbon tetrachloride to the trichloromethyl radical. Biochem. Pharmacol. 31 (5):615–24. doi:10/1016/0006-2952(82)90440-3.
  • Noguchi, T., K. L. Fong, E. K. Lai, L. Olson, and P. B. McCay. 1982a. Selective early loss of polypeptides in liver microsomes of CCl4-treated rats. Relationship to cytochrome P-450 content. Biochem. Pharmacol. 31 (5):609–14. doi:10.1016/0006-2952(82)90439-7.
  • OECD (Organisation for Economic Co-operation and Development). 2010. Including Benchmark Dose And Linear Extrapolation. NOAELS And NOELS, LOAELS And LOELS.
  • Packer, J. E., T. F. Slater, and R. L. Willson. 1978. Reactions of the carbon tetrachloride-related peroxy free radical (CCl3O2.) with amino acids: Pulse radiolysis evidence. Life Sci. 23 (26):2617–20. doi:10.1016/0024-3205(78)90378-8.
  • Penn, I. 1988. Tumors of the immunocompromised patient. Annu. Rev. Med. 39 (1):63–73. doi:10.1146/annurev.me.39.020188.000431.
  • Petterino, C., S. Naylor, S. Mukaratirwa, and A. Bradley. 2015. Adrenal gland background findings in CD-1 (Crl: CD-1(ICR)BR) mice from 104-week carcinogenicity studies. Toxicol. Pathol 43 (6):816–24. doi:10.1177/0192623315587921.
  • Pohl, L. R., R. D. Schulick, R. J. Highet, and J. W. George. 1984. “Reductive-oxygenation mechanism of metabolism of carbon tetrachloride to phosgene by cytochrome P-450.“ Mol Pharmacol 25 (2): 318–21.
  • Pound, A. W. 1978. Influence of carbon tetrachloride on induction of tumours of the liver and kidneys in mice by netrosamines. Br. J. Cancer 37 (1):67–75. doi:10.1038/bjc.1978.10.
  • Pound, A. W., T. A. Lawson, and L. Horn. 1973. Increased carcinogenic action of dimethylnitrosamine after prior administration of carbon tetrachloride. Br. J. Cancer 27 (6):451–59. doi:10.1038/bjc.1973.57.
  • Quist, E. M., G. A. Boorman, J. M. Cullen, R. R. Maronpot, A. K. Remick, J. A. Swenberg, L. Freshwater, and J. F. Hardisty. 2019. Reevaluation of hepatocellular neoplasms in CD-1 mice from a 2-year oral carcinogenicity study with permethrin. Toxicol. Pathol 47 (1):11–17. doi:10.1177/0192623318809304.
  • Racay, P., P. Kaplan, V. Mezesova, and L. Lehotsky. 1997. Lipid peroxidation both inhibits Ca(2+)-ATPase and increases Ca2+permeability of endoplasmic reticulum membrane. Biochem. Mol. Biol. Int. 41 (4):647–55. doi:10.1080/15216549700201691.
  • Raucy, J. L., J. C. Kraner, and J. M. Lasker. 1993. Bioactivation of halogenated hydrocarbons by cytochrome P4502E1. Crit. Rev. Toxicol. 23 (1):1–20. doi:10.3109/10408449309104072.
  • Recknagel, R. O., E. A. Glende. 1973. Carbon tetrachloride hepatotoxicity: An example of lethal cleavage. Crit. Rev. Toxicol. 2 (3):263–97. doi:10.3109/10408447309082019.
  • Reinke, L. A., and E. G. Janzen. 1991. Detection of spin adducts in blood after administration of carbon tetrachloride to rats. Chem. Biol. Interact. 78 (2):155–65. doi:10.1016/0009-2797(91)90011-u.
  • Reuber, M. D., and E. L. Glover. 1967. Hyperplastic and early neoplastic lesions of the liver in Buffalo strain rats of various ages given subcutaneous carbon tetrachloride. J. Natl. Cancer Inst. 38 (6):891–99. doi:10.1093/jnci/38.6.891.
  • Reuber, M. D., and E. L. Glover. 1970. Cirrhosis and carcinoma of the liver in male rats given subcutaneous carbon tetrachloride. J. Natl. Cancer Inst. 44 (2):419–27. doi:10.1093/jnci/44.2.419.
  • Rocchi, P., G Prodi, S Grilli, and A. M. Ferreri. 1973. In vivo and in vitro binding of carbon tetrachloride with nucleic acids and proteins in rat and mouse liver. Int. J. Cancer 11 (2):419–25. doi:10.1002/ijc.2910110219.
  • Rosol, T. J., J. T. Yarrington, J. Latendresse, and C. C. Capen. 2001. Adrenal gland: Structure, function, and mechanisms of toxicity. Toxicol. Pathol 29 (1):41–48. doi:10.1080/019262301301418847.
  • Ruprah, M., T. G. K. Mant, and R. J. Flanagan. 1985. Acute carbon tetrachloride poisoning in 19 patients: Implications for diagnosis and treatment. Lancet 325 (8436):1027–29. doi:10.1016/s0140-6736(85)91624-1.
  • Seed, J., E. W. Carney, R. A. Corley, K. Crofton, J. M. DeSesso, P. M. Foster, R. Kavlock, G. Kimmel, J. Klaunig, M. E. Meek, et al. 2005. Overview: Using mode of action and life stage information to evaluate the human relevance of animal toxicity data. Crit. Rev. Toxicol. 35 (8–9):664–72. doi:10.1080/713608373.
  • Sipes, I. G., G. Krishna, and J. R. Gillette. 1977. Bioactivation of carbon tetrachloride, chloroform and bromotrichloromethane: Role of cytochrome P-450. Life Sci. 20 (9):1541–48. doi:10.1016/0024-3205(77)90446-5.
  • Slater, T. F. 1981. Free radicals as reactive intermediates in tissue injury. Adv. Exp. Med. Biol. 136:575–89. doi:10.1007/978-1-4757-0674-1_42.
  • Slater, T. F. 1982. Activation of carbon tetrachloride: Chemical principles and biological significance. In Free radicals, lipid peroxidation and cancer, ed. D. C. H. McBrien, and T. F, pp. 243–74. New York, NY: Academic Press.
  • Sonich-Mullin, C., R. Fielder, J. Wiltse, K. Baetcke, J. Dempsey, P. Fenner-Crisp, D. Grant, M. Hartley, A. Knaap, D. Kroese, et al. 2001. IPCS conceptual framework for evaluating a node of action for chemical carcinogenesis. Regul. Toxicol. Pharmacol. 34(2):146–52. doi:10.1006/rtph.2001.1493.
  • Takahashi, S., T. Takahashi, S. Mizobuchi, M. Matsumi, K. Morita, M. Miyazaki, M. Namba, R. Akagi, and M. Hirakawa. 2002. Increased cytotoxicity of carbon tetrachloride in a human hepatoma cell line overexpressing cytochrome P450 2E1. J. Int. Med. Res. 30 (4):400–05. doi:10.1177/147323000203000406.
  • Takano, T., M. Tatematsu, R. Hasegawa, K. Imaida, and N. Ito. 1980. Dose-response relationship for the promoting effect of phenobarbital on the induction of liver hyperplastic nodules in rats exposed to 2-fluorenylacetamide and carbon tetrachloride. Gan 71 (4):580–81.
  • Takizawa, S., H. Watanabe, Y. Naito, and S. Inoue. 1975. Preparative action of carbon tetrachloride in liver tumorigenesis by a single application of N-butylnitrosourea in male ICR/JCL strain mice. Gan 66 (6):603–14.
  • Tanaka, T., H. Mori, and G. M. Williams. 1987. Enhancement of dimethylnitrosamine-initiated hepatocarcinogenesis in hamsters by subsequent administration of carbon tetrachloride but not phenobarbital or p, p ′-dichlorodiphenyltrichloroethane. Carcinogenesis 8 (9):1171–78. doi:10.1093/carcin/8.9.1171.
  • Thoolen, B., R. R. Maronpot, T. Harada, A. Nyska, C. Rousseaux, T. Nolte, D. E. Malarkey, W. Kaufmann, K. Kuttler, U. Deschl, et al. 2010. Proliferative and nonproliferative lesions of the rat and mouse hepatobiliary system. Toxicol. Pathol 38 (7_suppl):5S–81S. doi:10.1177/0192623310386499.
  • Tischler, A. S., J. F. Powers, and J. Alroy. 2004. Animal models of pheochromocytoma. Histol. Histopathol. 19:883–95. doi:10.14670/hh-19.883.
  • Tomenson, J. A., C. E. Baron, J. J. O’Sullivan, J. C. Edwards, M. D. Stonard, R. J. Walker, and D. M. Fearnley. 1995. Hepatic function in workers occupationally exposed to carbon tetrachloride. Occup Environ. Med 52 (8):508–14. doi:10.1136/oem.52.8.508.
  • Tracey, J. P., and P. Sherlock. 1968. Hepatoma following carbon tetrachloride poisoning. N Y State J .Med 68 (16):2202–04.
  • U.S. EPA (U.S. Environmental Protection Agency). February 2010. “Toxicological review of carbon tetrachloride (CAS no. 56-23-5).“ In Support Of Summary Information On The Int. Risk Information System (IRIS. EPA Document #EPA/635/R-08/005F.
  • U.S. EPA (U.S. Environmental Protection Agency). October 2020. “Risk evaluation for carbon tetrachloride (Methane, Tetrachloride) CASRN: 56-23-5.“ EPA. Document# EPA-740-R1-8014.
  • U.S. FDA (U.S. Food and Drug Administration) May 2001. Guidance for industry. Statistical aspects of the design, analysis, and interpretation of chronic rodent carcinogenicity studies of pharmaceuticals.
  • Weber, L. W. D., M. Boll, and A. Stampfl. 2003. Hepatotoxicity and mechanism of action of haloalkanes: Carbon tetrachloride as a toxicological model. Crit. Rev. Toxicol. 33 (2):105–36. doi:10.1080/713611034.
  • Weisburger, E. K. 1977. Carcinogenicity studies on halogenated hydrocarbons. Environ. Health Perspect. 21:7–16. doi:10.1289/ehp.77217.
  • Wong, F. W., W. Chan, and S. S. Lee. 1998. Resistance to carbon tetrachloride-induced hepatotoxicity in mice which lack CYP2E1 expression. Toxicol. Appl. Pharmacol 153 (1):109–18. doi:10.1006/taap.1998.8547.
  • Yamate, J., M. Tajima, S. Kudow, and S. Sannai. 1990. Background pathology in BDF 1 mice allowed to live out their life-span. Lab. Anim (NY) 24 (4):332–40. doi:10.1258/002367790780865976.
  • Yamazaki, Y., S. Kakizaki, N. Horiguchi, H. Takagi, M. Mori, and M. Negishi. 2005. Role of nuclear receptor CAR in carbon tetrachloride-induced hepatotoxicity. World J. Gastroenterol 11 (38):5966–72. doi:10.3748/wjg.v11.i38.5966.
  • Younes, M., and C. P. Siegers. 1985. The role of iron in the paracetamol- and CCl4-induced lipid peroxidation and hepatotoxicity. Chem. Biol. Interact. 55:327–34. doi:10.1016/s0009-2797(85)80139-3.
  • Zalatnai, A., I. Sarosi, A. Rot, and K. Lapsis. 1991. Inhibitory and promoting effects of carbon tetrachloride-induced liver cirrhosis on the diethylnitrosamine hepatocarcinogenesis in rats. Cancer Lett. 57 (1):67–73. doi:10.1016/0304-3835(91)90065-p.